Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis

P S McNamara1, B F Flanagan, A M Selby

  • 1Dept of Child Health, University of Liverpool, Institute of Child Health, Alder Hey Children's Hospital, Liverpool, UK. mcnamp@liv.ac.uk

Insights

Respiratory syncytial virus (RSV) bronchiolitis involves significant pulmonary inflammation. Tumor necrosis factor-alpha and interleukin-6 levels are elevated in infants with RSV bronchiolitis, decreasing in preterm infants over illness duration.

Area of Science:

  • Pediatric Respiratory Medicine
  • Immunology
  • Virology

Background:

  • Respiratory syncytial virus (RSV) bronchiolitis is a leading cause of severe infant respiratory illness.
  • Understanding the pulmonary inflammatory response is crucial for managing RSV bronchiolitis.

Purpose of the Study:

  • To characterize changes in pulmonary pro- and anti-inflammatory responses during RSV bronchiolitis in infants.
  • To compare inflammatory markers between term and preterm infants with RSV bronchiolitis.

Main Methods:

  • Non-bronchoscopic bronchoalveolar lavage was performed on infants with RSV bronchiolitis and controls.
  • Measurements included tumor necrosis factor-alpha (TNF-alpha), soluble TNF receptor (sTNFR), and interleukin-6 (IL-6) mRNA and protein.
  • Samples were collected on day of intubation (Day 1) and day of extubation (Day X).

Main Results:

  • Infants with RSV bronchiolitis showed higher TNF-alpha and IL-6 mRNA and protein than controls on Day 1.
  • In preterm infants, TNF-alpha and IL-6 proteins decreased from Day 1 to Day X.
  • sTNFR concentrations differed between groups on Day 1 but did not change over time.

Conclusions:

  • Elevated TNF-alpha and IL-6 in RSV-infected lungs suggest a role in disease pathogenesis.
  • The decrease in TNF-alpha and IL-6 in preterm infants may correlate with their prolonged illness course.
  • These findings highlight the inflammatory dynamics in infant RSV bronchiolitis.

Related Concept Videos

Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...